Key considerations to cancer institute’s gen AI deployment

The overhype of generative AI was unavoidable last year, yet despite all the distraction, unproven benefits, and potential pitfalls, Dana-Farber Cancer Institute CIO Naomi Lenane didn’t want to ban the technology outright. It was undeniably groundbreaking, and there could be interesting things the institute’s employees might be able to do with it.

But allowing free, unfettered use of the public gen AI platforms was not an option. So DFCI took three main steps to deploy gen AI in a controlled way. That included setting up a governance framework, building an internal tool that was safe for employees to use, and developing a process for vetting gen AI embedded in third-party systems.

Read full article at CIO magazine.